Lindsay Mark F. 4
4 · Vivos Therapeutics, Inc. · Filed Aug 10, 2021
Insider Transaction Report
Form 4
Lindsay Mark F.
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-08-05$2.72/sh+30,000$81,600→ 46,667 totalExercise: $2.72Exp: 2026-08-05→ Common Stock (46,667 underlying)
Footnotes (1)
- [F1]30,000 stock options granted on August 5, 2021. One-half vested immediately and one-eighth vests quarterly every three months through August 5, 2022.